Funded Grants

PI Name Sort descending PI Organization Title Grant Number Initiative Program Official
Yeh, Jennifer M.

Boston Children'S Hospital
United States

Can risk-reducing medications improve breast cancer prevention in childhood and adolescent cancer survivors? Comparative modeling to inform care 5R01CA261874-03 Eileen Dimond, R.N., M.S.
Yeh, Jennifer M.

Boston Children'S Hospital
United States

Genetic testing to guide pediatric cancer care and follow up: using anthracycline-associated cardiac toxicity as a model for the future 5R01CA227576-05 Eileen Dimond, R.N., M.S.
Yendamuri, Saikrishna

Roswell Park Cancer Institute Corp
United States

Metformin for chemoprevention of lung cancer in obese subjects at high risk 3R01CA255515-04S1 Eva Szabo, M.D.
Yilmaz, Omer

Massachusetts Institute Of Technology
United States

PROSPECT - Stem cell models 1OT2CA297570-01 Asad Umar, D.V.M., Ph.D.
Yost, Kathleen J

Corewell Health
United States

Cancer Research Consortium of West Michigan (CRCWM) 5UG1CA189860-11 Vanessa A. White, M.P.H.
You, Ming

Methodist Hospital Research Institute
United States

Inhibition of Oral Tumorigenesis by Antitumor B 7R01CA205633-06 Eva Szabo, M.D.
You, Ming

Methodist Hospital Research Institute
United States

Targeting phenethyl isothiocyanate to mitochondria in lung carcinogenesis 5R01CA280746-02 John Clifford, Ph.D.
You, Ming

Methodist Hospital Research Institute
United States

Chemoprevention of lung cancer by targeting lonidamine to mitochondria 5R01CA232433-05 John Clifford, Ph.D.
Young, Steven L

Duke University
United States

Collaborative Center to Develop Improved Diagnostic and Therapeutic Approaches to Endometriosis 5P01HD106485-04 Goli Samimi, Ph.D., M.P.H.
Yu, Dihua

University Of Tx Md Anderson Can Ctr
United States

Exploring novel strategies for immunoprevention of estrogen receptor negative breast cancer 5R01CA270010-03 PA-20-185 (Parent R01 Clinical Trial Not Allowed) Marjorie Perloff, M.D.